Sepsis Diagnostics Market

BioMérieux (France), Medtronic PLC (Ireland), Becton Dickinson and Company (US) and Danaher Corporation (US) are Leading Players in the Sepsis Diagnostics Market

The global sepsis diagnostics market is projected to reach USD 890 million by 2029 from USD 634 million in 2024, at a CAGR of 7.0% from 2024 to 2029. The expanding objective includes rising geriatric population, increasing sepsis prevalence, high incidence of HAIs, increasing adoption of mesh in sepsis diagnostics surgeries, technological advancement, increasing number of surgical procedures, and new product development, These key factors are encouraging the growth of sepsis diagnostics market globally.

The sepsis diagnostics market is moderately competitive, with both established companies and upcoming competitors for the same market share. As of 2023, the key player operating in the global sepsis diagnostics market are bioMérieux S.A. (France), Becton Dickinson and Company (US), Danaher Corporation (US), T2 Biosystems (US), QIAGEN N.V. (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific (US), Bruker Corporation (US), Abbott Laboratories (US) and QuidelOrtho Corporation (US).

The key strategies adopted by the top players in this market in the last four years include product approvals, acquisitions and expansions. In 2023, a major share of the Sepsis diagnostics market was held by bioMérieux S.A. (France), Becton Dickinson and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US) and QIAGEN N.V. (Germany).

To know about the assumptions considered for the study download the pdf brochure

BioMérieux (France)

bioMérieux is a multinational medical technology company with a significant global presence in the market and one of the leading players in the global sepsis diagnostics market.. The company operates in many countries and has manufacturing, R&D facilities and sales offices worldwide. Medtronic manufactures and markets wide range of automated devices and services including innovative and effective sepsis diagnostics devices. The end users of company’s products are hospitals, clinics, third-party healthcare providers, other institutions (including governmental healthcare programs and group purchasing organizations), and distributors.

Medtronic PLC (Ireland)

Medtronic focuses on strengthening its R&D capabilities by increasing its investment in research, product approvals, and expanding geographic reach worldwide. The company expands its molecular diagnostics and infectious disease testing product portfolio in the market by receiving FDA and CE approvals for many products and is expected to witness high growth with a strong geographical presence and robust product portfolio for sepsis diagnostics.

Becton Dickinson And Company (US)

Becton Dickinson (BD) is one of the leading medical technology companies in the world. It develops, manufactures, and markets medical devices, instrument systems, and reagents. BD offers various products for global sepsis diagnostics such as blood culture medium, automated blood culture instruments, blood culture consumables, and laboratory data management software. BD commands a significant share in the global sepsis diagnostics market and has an extensive distribution network in both developed and developing nations for the supply of its medical products. The company concentrates on developing new products and focusing its efforts on gaining product approvals thus expecting to grow rapidly in the coming years.

Danaher Corporation (US)

Danaher Corporation is a manufacturer and supplier of medical devices and surgical equipments. Danaher provides a range of solutions for sepsis diagnostics. The company focuses primarily on acquisitions and partnerships to maintain its market position and ensure future growth. Danaher expanded its molecular diagnostics business by the acquisition of Cepheid. In the global medical devices market, the company is known for incorporating advanced surgical technologies into its products. Danaher is one of the key market players in the sepsis diagnostics market. The company invests in R&D to produce its diverse product portfolio.

Related Reports:

Sepsis Diagnostics Market By Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), EndUser - Global Forecast to 2029

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Sepsis Diagnostics Market Size,  Share & Growth Report
Report Code
MD 4575
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved Protection Status